Methods for monitoring and documenting adverse drug reactions

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 3, 1996, Pages 112-129

  Venulet, J ^a   Ten Ham, M ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; CLINICAL TRIAL; DRUG SURVEILLANCE PROGRAM; HUMAN; METHODOLOGY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANIMALS; CLINICAL TRIALS; HUMANS; RESEARCH DESIGN;

EID: 0030111227     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Anonymous 1977 Intensified adverse drug reaction reporting scheme. New Zealand Med J 85: 157-158
2. Anonymous 1992 Basic requirements for the use of terms for reporting adverse drug reactions. Pharmacoepidemiology 1: 39-45
3. Bankovski Z 1994 Definitions of adverse drug reactions and minimum requirements for their use. In: Fracchia GN (ed) European medicines research. IOS Press, Amsterdam
4. Begaud B, Evreux JC, Jouglard J, Lagier G 1985 Imputabilité des effets inattendus ou toxiques des medicaments. Therapie 40: 111-118
5. Begaud B, Chaslerie A, Fourrier A et al 1992 Methodological approaches in pharmacoepidemiology. Applications to spontaneous reporting. ARME-P Ed, Bordeaux
6. Begaud B, Chaslerie A, Fourrier A et al 1993 Etudes de cohortes en pharmacovigilance. ARME-P Ed, Bordeaux.
7. Begaud B, Chaslerie A, Dangoumau J et al 1995 Dictionnaire de pharmaco-epidemiologie. ARME-P Ed, Bordeaux
8. Benichou C 1994 Adverse drug reactions. A practical guide to diagnosis and management. Wiley, Chichester
9. Commission of the European Communities, CPMP Working Party on Pharmacovigilance 1991 Document III/3445/91 -EN, Final.
10. Conn HA, Poynard T 1994 Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 236: 619-632
11. Dollery CT, Rawlins MD 1977 Monitoring adverse reactions to drugs. Br Med J 1: 96-97 (1977)
12. Eysenck HJ 1992 Meta-analysis, sense or non-sense? Pharm Med 6: 113-119
13. Finney DH 1986 Statistical logic in the monitoring of reactions to therapeutic drugs. In: Inman HWH(ed) Monitoring for drug safety. MTP Press, Lancaster
14. Grahame-Smith DG, Aronson JK 1992 Oxford textbook of clinical pharmacology and drug therapy. Oxford University Press, Oxford
15. Helling M, Venulet J 1974 Drug recording and classification WHO Research Centre for International Monitoring of Adverse Reactions to Drugs. Methods Inform Med 13: 169-178
16. Hoigné R, Stocker F, Barbier A et al 1978 Dual purpose of inpatient drug monitoring by physicians in two teaching hospitals in Berne. In: Ducror H et al (eds) Computer aid to drug therapy and to drug monitoring. North Holland Publishing. Amsterdam, pp 9-19
17. Hurwitz N 1969 Admissions to hospital due to drugs. Br Med J 1: 539
18. Inman WHW 1981 Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Br Med J 282: 1216-1217
19. Karch FE, Lasagna L 1977 Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 21: 247-254
20. Lawson DH, Henry DA 1977 Monitoring adverse reactions to new drugs: "restricted release" or "monitored release". Br Med J 1: 691-692
21. Lawson DH, Hutcheon AW, Jick H 1979 Life threatening drug reactions amongst medical in-patients. Scot Med J 24: 127-130
22. Levy M, Kevitz H, Altwein W, Hillebrand J, Eliakim M 1981 Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 17: 25-31
23. Mach EP, Venulet J 1975 The economics of adverse reactions to drugs WHO Chronicle 29: 79-84
24. Martinez C, Walker A 1995 Hypothesis testing using spontaneous reports as a source for case-control studies. Pharmacoepidemiol Drug Saf 4: S69
25. Moore ND, Mammeri M, Carrara O, Desechalliers J-P, Hoblet C 1975 Incidence and cost of adverse drug reactions in a department of internal medicine of a general hospital using a computerized hospital management system. Pharmacoepidemiol Drug Saf 4: S72
26. Moore ND, Lecointre D, Noblet C, Mabille M 1995 Serious adverse drug reactions in a department of internal medicine: incidence and cost analysis. Pharmacoepidemiol Drug Saf 4: S74
27. Rawlins MD, Thompson JW 1977 Pathogenesis of adverse drug reactions. In: Davis DN (ed) Textbook on adverse drug reactions. Oxford University Press, Oxford, pp 10-31
28. Reidenberg MM, Lowenthal DT 1968 Adverse non-drug reactions. N Engl J Med 279: 678
29. Spitzer WO 1991 Meta-meta-analysis: unanswered questions about aggregating data. J Clin Epidemiol 2: 103-107
30. Ten Ham M 1992a WHO's role in international ADR monitoring. Post Marketing Surveillance 5: 223-230
31. Ten Ham M 1992b Counterfeit drugs, implications for health. Adv Drug React Toxicol Rev 11: 59-65
32. Ten Ham M 1994 Monitoring of adverse drug reactions: role of WHO European Pharma Law Centre, Pharma Law Report.
33. Thompson SG, Pocock SJ 1991 Can meta-analysis be trusted? Lancet 338: 1127-1130
34. Venulet J 1974 From experimental to social pharmacology. Int J Clin Pharmacol Ther 10: 203-205 (1974)
35. Venulet J 1977a Monitoring of adverse drug reactions in phase I: from animal to man. Adv Clin Pharmacol 13: 248-264
36. Venulet J 1977b Methods of monitoring adverse reactions to drugs. In: Jucker E (ed) Progress in drug research (Vol 21). Birkhäuser, Basel, pp 231-292
37. Venulet J 1978 Aspects of social pharmacology In: Jucker E (ed) Progress in drug research (Vol 22). Birkhäuser, Basel, pp 10-25
38. Venulet J 1992 Role and place of causality assessment. Pharmacoepidemiol Drug Saf 1: 225-2234
39. Venulet J, Ciucci A, Berneker G-C 1980 Standardized assessment adverse drug reactions associations. Int J Clin Pharmacol 18: 381-388
40. Venulet J, Berneker G-C, Ciucci AC 1982 Assessing causes of adverse drug reactions. Academic Press, London
41. Venulet J, Blatner R, von Bulow J, Berneker G-C 1984 How good are articles on adverse drug reactions? Br Med J 248: 251-254
42. Venuler J, Ciucci AC, Berneker G-C 1986 Updating a method for causality assessment of adverse drug reactions. Int J Clin Pharmacol 24: 559-568
43. Wallace SM, Suveges LG, Gesy KF 1995 Adverse drug reaction reporting. Part I: a survey of pharmacists and physicians in Saskatchewan. Drug Inform J 26: 571-579
44. WHO Collaborating Centre 1991 For International Drug Monitoring Definitions as adopted by National Centres Participating in the WHO International Drug Monitoring Programme. September 1991, unpublished document
45. WHO Collaborating Centre for Drug Statistics Methodology 1993 Guidelines for ODD (2nd ed). ISBN 82-90312-19-9, Oslo
46. World Health Organization International Drug Monitoring 1972 The role of national centres. Technical Report Series 498: Geneva
47. World Health Organization 1995 WHO Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products. Technical Report Series, to be published, Geneva